The role of Product Development Partnerships in research and development for neglected diseases

References 

1. Moran M, Ropars AL, Guzman J, Diaz J, Garrison C. The New Landscape of Neglected Disease Drug Development. London: The Wellcome Trust; 2005. http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_publishing_group/documents/web_document/wtx026592.pdf [accessed 23 June 2009].
2. Croft S. Public-private partnerships: from there to here. Trans R Soc Trop Med Hyg. 2005;995:S9–14
3. Meredith S, Ziemba E The new landscape of product development partnerships (PDPs). In: Matlin S, De Francisco A, Sundaram L, Faich H-S, Gehner M, editors. Health Partnerships Review. Focusing collaborative efforts on research and innovation for the health of the poor. Geneva: Global Forum for Health Research; 2008, p. 11-5. Available: http://www.globalforumhealth.org/Media-Publications/Publications/Health-Partnerships-Review [accessed 12 August 2009].
4. Buse K, Walt G. Global public-private partnerships – what are the issues for global governance (part I and II). Bull World Health Organ. 2000;78:699–709
   • MEDLINE
5. Kettler H, Towse A. Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty, London: Office of Health Economics.
6. Feuer C. Tuberculosis Research and Development: A Critical Analysis of Funding Trends, 2005-2006. New York: Treatment Action Group;2008. http://www.treatmentactiongroup.org/assets/0/16/42/196/198/a06bc658-c108-4bfd-986f-17997f85b22c.pdf [accessed: 13 August 2009].
7. HIV Vaccines and Microbicides Resource Tracking Working Group. Sustaining the HIV prevention research agenda: funding for research and development of HIV vaccines, microbicides and other new prevention options (2000-2007). New York: AIDS Vaccine Advocacy Coalition; 2008 http://www.hivresourcetracking.org/downloads/RT_report_August2008.pdf [accessed 13 August 2009].
8. Malaria R&D Alliance. Malaria Research & Development. An Assessment of Global Investment. Malaria R&D Alliance; 2005. http://www.malariavaccine.org/files/MalariaRD_Report_complete.pdf [accessed 13 August 2009].
9. Moran M, Guzman J, Ropars AL, McDonald A, Sturm T, Jameson N et al. Neglected Disease Research & Development: How Much Are We Really Spending? Sydney: The George Institute of International Health; 2009. http://www.thegeorgeinstitute.org/shadomx/apps/fms/fmsdownload.cfm?file_uuid=409D1EFD-BF15-8C94-E71C-288DE35DD0B2&siteName=iih [accessed 16 June 2009].
10. Moran M, Guzman J, Ropars AL, McDonald A, Sturm T, Jameson N, et al. Neglected Disease Research and Development: How Much Are We Really Spending?. PLoS Med. 2009;6:e1000030;[accessed 12 August 2009]
11. WHO. Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health; 2001. Geneva: World Health Organization. http://www.emro.who.int/cbi/pdf/CMHReportHQ.pdf [accessed 12 August 2009].
12. DFID. Call for Expressions of Interest for DFID Product Development Partnership (PDP) Funding. London: DFID; 2009. http://www.research4development.info/news.asp?ArticleID=50349 [accessed 19 June 2009].
13. Serdobova I, Kieny MP. Assembling a Global Vaccine Development Pipeline for Infectious Diseases in the Developing World. Am J Public Health. 2006;22:1554–1559
14. Moran M, Guzman J, Ropars A-L, Jorgensen M, McDonald A, Potter S, et al. The Malaria Product Pipeline: Planning for the Future. London/Sydney: The George Institute for International Health; 2007. http://www.thegeorgeinstitute.org/shadomx/apps/fms/fmsdownload.cfm?file_uuid=1ABDE79C-DA73-20B3-D6E1-F7AF25011EC9&siteName=iih [accessed 10 December 2009].
15. Pekar N, editor. The Economics of TB Drug Development. New York: Global Alliance for TB Drug Development; 2001. http://www.tballiance.org/downloads/publications/TBA_Economics_Report.pdf [accessed 10 December 2009].
16. Roll Back Malaria Partnership. The Global Malaria Action Plan. Geneva: World Health Organization; 2008. http://www.rollbackmalaria.org/gmap/gmap.pdf [accessed 18 November 2009].
17. Foundation for Innovative New Diagnostics, Special Programme for Research & Training in Tropical Diseases. Diagnostics for tuberculosis: Global demand and market potential. Geneva: World Health Organization; 2006. http://www.finddiagnostics.org/export/sites/default/resource-centre/find_documentation/pdfs/tbdi_full.pdf [accessed 10 December 2009].
18. Foundation for Innovative New Diagnostics. Product pipeline. Geneva: FIND; 2009. http://www.finddiagnostics.org/programs/tb/pipeline.html [accessed 10 December 2009].
19. Irish Aid. Strategy for supporting Global Health Partnerships. 2006-2010; 2007. Dublin: Irish Aid. http://www.irishaid.gov.ie/hivandaids/downloads/Irish_Aid_GHP_Strategy.doc [accessed 24 July 2009].
20. Ager A, McGowan J, Snewin V, Walker S. Central Research Department Strategy Paper: Investing in new tools for HIV/AIDS, malaria and tuberculosis through Public Private Partnerships. London: DFID; 2005. http://www.research4development.info/pdf/articles/malaria_PDP_strategy_paper.pdf [accessed 27 July 2009].
21. Herrling P. Making drugs accessible to poor populations: a funding model. Geneva: Global Forum for Health Research; 2009. http://www.globalforumhealth.org/Media-Publications/Publications/Global-Forum-Update-on-Research-for-Health-Volume-5/Global-Forum-Update-on-Research-for-Health-Volume-5-Fostering-innovation-for-global-health-Individual-articles [accessed 1 April 2010].
22. MMV. Annual Report 2008. Geneva: Medicines for Malaria Venture; 2009 http://www.mmv.org/IMG/pdf/mmvAR08_Spreads.pdf [accessed 28 July 2009].
23. Drugs for Neglected Diseases (DNDi). 2008-09 Annual Report. Delivering Innovation and Building a Robust Pipeline. Geneva: DNDi; 2009. http://www.dndi.org/images/stories/pdf_aboutDNDi/ar2009.pdf [accessed 17 August 2009].